 - Laboratory safety tests, including a complete blood count CBC, a comprehensive metabolic panel CMP, coagulation studies PT and APTT and a urinalysis UA performed at Visit 1 study entry, Visit 6 completion of transit scintigraphy and final dose of study medication, and Visit 7 study completion. A urine screen for drugs of abuse will be performed once at Visit 1 study entry. 